Cargando…
Effective inactivation of a wide range of viruses by pasteurization
BACKGROUND: Careful selection and testing of plasma reduces the risk of blood‐borne viruses in the starting material for plasma‐derived products. Furthermore, effective measures such as pasteurization at 60°C for 10 hours have been implemented in the manufacturing process of therapeutic plasma prote...
Autores principales: | Gröner, Albrecht, Broumis, Connie, Fang, Randel, Nowak, Thomas, Popp, Birgit, Schäfer, Wolfram, Roth, Nathan J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7169671/ https://www.ncbi.nlm.nih.gov/pubmed/29148053 http://dx.doi.org/10.1111/trf.14390 |
Ejemplares similares
-
Nanofiltration as a robust method contributing to viral safety of plasma‐derived therapeutics: 20 yearsʼ experience of the plasma protein manufacturers
por: Roth, Nathan J., et al.
Publicado: (2020) -
Inactivation of yellow fever virus with amotosalen and ultraviolet A light pathogen‐reduction technology
por: Girard, Yvette A., et al.
Publicado: (2020) -
Impact of cold storage on platelets treated with Intercept pathogen inactivation
por: Six, Katrijn R., et al.
Publicado: (2019) -
Inactivation of Plasmodium falciparum in whole blood using the amustaline and glutathione pathogen reduction technology
por: Sow, Cissé, et al.
Publicado: (2020) -
Robust inactivation of Plasmodium falciparum in red blood cell concentrates using amustaline and glutathione pathogen reduction
por: Sow, Cissé, et al.
Publicado: (2022)